Published inThe ExpressionBeyond one-ply: Understanding the layers of consent and risk in clinical trialsFrom the lab to the clinic to the local newspaper, managing expectations around stem cell therapies is everyone’s job.May 16, 2017May 16, 2017
Published inThe ExpressionThe value proposition for stem cell therapiesAs more regenerative medicine research moves toward clinical trials, it’s a perfect time to be asking not just ‘what can we achieve?’, but…Apr 25, 2017Apr 25, 2017
Published inThe ExpressionHow an old drug is coaxing new life into damaged brainsThanks to a chance discovery, an Ontario Institute of Regenerative Medicine (OIRM) research team is hot on the heels of a potential…Jan 26, 2016Jan 26, 2016
